journal article·2018-07-04Open access

Enhancing cisplatin delivery to hepatocellular carcinoma HepG2 cells using dual sensitive smart nanocomposite

Farzaneh Salimi, Karim Akbari Dilmaghani, Effat Alizadeh, Abolfazl Akbarzadeh, Soodabeh Davaran

Abstract

Targeted entrance and accumulation of higher doses of drugs into malignant cells could help in intensification of tumor specific cytotoxicity. A dual-responsive nanogel, poly(N-isopropylacrylamide)-co-poly(N,N-(dimethylamino)ethyl methacrylate) [P(NIPAM-co-DMA)] containing N-isopropylacrylamide (NIPAM) as thermoresponsive monomer and N,N-(dimethylamino)ethyl methacrylate (DMA) as pH-responsive monomer and methylene-bis-acrylamide (MBA) as cross-linking agent, was synthesized by free radical emulsion polymerization. Cisplatin along with magnetic Fe3O4 nanoparticles (MNPs) was loaded into the nanogel by physically embedding the magnetic nanoparticles into hydrogel matrix after gelation to obtain drug-loaded magnetic nanocomposite [P(NIPAM-co-DMA)/Fe3O4]. Drug loading efficiencies and drug release profiles of cisplatin-loaded P(NIPAM-co-DMA) nanogel and P(NIPAM-co-DMA)/Fe3O4 nanocomposite were evaluated in vitro for controlled drug delivery in different temperature and pH conditions. Finally, the anticancer activity of P(NIPAM-co-DMA)/Fe3O4 nanocomposite on human liver HepG2 cells was evaluated. Nanogel and nanocomposite showed significantly higher (p < .05) cisplatin release at 40 °C compared to 37 °C and at pH 5.7 compared to pH 7.4, demonstrating their temperature and pH sensitivity, respectively. The cytotoxicity assay of drug free nanogel on HepG2 cell line indicated that the nanogel is biocompatible and suitable as drug carrier. Moreover, MTT assay revealed that the cisplatin-loaded nanocomposite represented significant superior cytotoxicity (p < .05) to HepG2 cells as compared with free cisplatin.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Faculty of Science, Urmia University, Urmia, Iran;

Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran;

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

Universal Scientific Education and Research Network (USERN), Tabriz, Iran;

Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran;

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

References (49)

Show source-provided references
1. 10.1016/j.ejpb.2008.06.01610.1016/j.ejpb.2008.06.016 ↗
2. 10.1039/c0dt00292e10.1039/c0dt00292e ↗
3. 10.2174/18715200777931404410.2174/187152007779314044 ↗
4. 10.1097/MAJ.0b013e31812dfe1e10.1097/MAJ.0b013e31812dfe1e ↗
5. 10.1081/DDC-12003042210.1081/DDC-120030422 ↗
6. Eatemadi A · Artif Cells Nanomed Biotechnol · 2016 · 44 · 100810.3109/21691401.2014.922568 ↗
7. 10.1080/1091581050020935310.1080/10915810500209353 ↗
8. 10.3109/21691401.2014.94464610.3109/21691401.2014.944646 ↗
9. 10.3109/21691401.2016.116091510.3109/21691401.2016.1160915 ↗
10. 10.1080/21691401.2016.122865810.1080/21691401.2016.1228658 ↗
11. 10.1002/anie.20050289310.1002/anie.200502893 ↗
12. 10.1039/C6NJ03332F10.1039/C6NJ03332F ↗
13. 10.1039/B9PY00300B10.1039/B9PY00300B ↗
14. 10.1016/j.jconrel.2008.04.01310.1016/j.jconrel.2008.04.013 ↗
15. 10.1039/b601776m10.1039/b601776m ↗
16. 10.1016/S0168-3659(02)00409-110.1016/S0168-3659(02)00409-1 ↗
17. 10.1039/C5RA22784D10.1039/C5RA22784D ↗
18. 10.1016/j.jconrel.2012.11.01210.1016/j.jconrel.2012.11.012 ↗
19. 10.4236/jeas.2013.3401310.4236/jeas.2013.34013 ↗
20. 10.1016/j.jconrel.2003.10.00710.1016/j.jconrel.2003.10.007 ↗
21. 10.1021/jp061055b10.1021/jp061055b ↗
22. 10.1021/jp077633l10.1021/jp077633l ↗
23. 10.1016/j.biomaterials.2013.07.09210.1016/j.biomaterials.2013.07.092 ↗
24. Kurd K · Artif Cells Nanomed Biotechnol · 2016 · 44 · 1031
25. 10.1002/jbm.a.3037410.1002/jbm.a.30374 ↗
26. 10.1016/j.reactfunctpolym.2014.07.02410.1016/j.reactfunctpolym.2014.07.024 ↗
27. 10.1016/j.colsurfb.2012.07.00910.1016/j.colsurfb.2012.07.009 ↗
28. 10.1021/la010105v10.1021/la010105v ↗
29. 10.3109/21691401.2014.98280310.3109/21691401.2014.982803 ↗
30. Akbarzadeh A · Int J Nanomedicine · 2012 · 7 · 511
31. 10.1021/ja207150n10.1021/ja207150n ↗
32. 10.1002/marc.20050076910.1002/marc.200500769 ↗
33. 10.1002/mabi.20120012210.1002/mabi.201200122 ↗
34. 10.1002/adma.20050104310.1002/adma.200501043 ↗
35. 10.1016/j.carbpol.2012.09.00310.1016/j.carbpol.2012.09.003 ↗
36. 10.1039/C5NJ02504D10.1039/C5NJ02504D ↗
37. 10.1016/j.biomaterials.2013.01.08310.1016/j.biomaterials.2013.01.083 ↗
38. 10.7314/APJCP.2014.15.1.4910.7314/APJCP.2014.15.1.49 ↗
39. 10.1016/j.msec.2008.10.00710.1016/j.msec.2008.10.007 ↗
40. 10.1016/j.ica.2012.05.01210.1016/j.ica.2012.05.012 ↗
41. 10.1039/C2TB00294A10.1039/C2TB00294A ↗
42. 10.1016/j.jconrel.2008.07.01910.1016/j.jconrel.2008.07.019 ↗
43. 10.1016/S1567-5394(02)00032-410.1016/S1567-5394(02)00032-4 ↗
44. Khalilov RI · Russian Plant Physiol · 1993 · 3 · 338
45. Youssef NA · Int J Pharm Sci Health Care · 2013 · 1 · 1
46. 10.1134/S000635091102014X10.1134/S000635091102014X ↗
47. Khalilov RI · Doklady Akad Nauk · 1992 · 4 · 850
48. Goldfeld MG · Doklady Akad Nauk SSSR · 1979 · 1 · 235
49. Rovshan K · Int J Pharm Pharm Sci · 2015 · 7 · 172